Delivery Order SPE2DB20D7059-SPE2DB25FQGG4
Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $2.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order valued at $5,234.78 by the Defense Logistics Agency (DLA) for the supply of Methylphenidate ER 27 mg tablets in quantities of 100 units per bottle. This is a firm fixed price, competitively awarded contract with an ultimate completion date of September 18, 2025. The award carries no set-aside designation, indicating the contract was competed among all eligible vendors. This delivery...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Methylphenidate ER 36 mg tablets (100-count units) with a ceiling value of $1,189.40. This firm fixed-price delivery order, which is not set-aside, represents a competitive award executed under AmerisourceBergen's larger Indefinite Delivery Contract with the Defense Logistics Agency Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Methylphenidate ER 18 mg tablets in a quantity of 100 units, valued at $4,817.50. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was competitively procured. The contract is scheduled for completion by September 12, 2025, and will be performed at AmerisourceBergen's corporate office location in...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order for Methylphenidate Extended Release 36mg tablets (100 count) with a ceiling value of $3,248.16 under a firm fixed-price contract type. The award was issued on August 11, 2025, with an ultimate completion date of the same day, and represents a non-set-aside, competitively awarded procurement from the Defense Logistics Agency's Medical Supply Chain. This...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide 4,563,512,599 units of Methylphenidate ER 18 mg tablets in 100-count bottles. The $1,263.10 contract has a completion date of February 2, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which falls under a larger indefinite delivery contract (IDC) valued at up to $999,999,999.00 awarded by...
- AmerisourceBergen Drug Corp, a leading pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract on July 14, 2025, valued at approximately $25.5K for the supply of Methylphenidate ER 18mg tablets (100 count). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation, under the Defense Logistics Agency's Medical Supply Chain. The contract is set to be completed by August 8, 2025, with performance taking place...
- AmerisourceBergen Drug Corp was awarded a delivery order by the Defense Logistics Agency (DLA) on September 18, 2025, for the supply of Methylphenidate ER 54 mg tablets (100-count bottles) with a ceiling value of $1,827.84. This is a firm fixed-price contract with an ultimate completion date of September 19, 2025, and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive, non-set-aside procurement issued under DLA's...
- The U.S. Defense Department's Medical Supply Chain awarded a $2,513.64 delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Methylphenidate ER 18 mg tablets (100-count units). This competitive award with firm fixed pricing represents a non-set-aside contract and is scheduled for completion by August 13, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $1,176.88 to AmerisourceBergen Drug Corp for the supply of Methylphenidate ER 27 mg tablets (100-count) on May 6, 2025, with completion scheduled for May 7, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance based in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,583 contract is for the supply of 100 tablets of Methylphenidate ER 18 mg, a medication used to treat attention deficit hyperactivity disorder (ADHD). The contract has an ultimate completion date of May 9, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite...